AI Article Synopsis
Article Abstract
Objective: Sodium intake is an important issue for patients with chronic kidney disease (CKD). The two most widely used methods to measure sodium are 24-h urinary sodium excretion (24HUNa), which can be difficult to perform routinely, and sodium intake by dietary recall, which can be inaccurate. This study evaluated use of the mean value of three spot urinary sodium (UNa) concentrations to estimate daily sodium intake in patients with CKD.
Methods: This cross-sectional study enrolled 305 patients with CKD, none of whom were on dialysis, who visited the nephrology clinic at the Asan Medical Center (Seoul, Korea). We performed three spot UNa tests, three calculations of the UNa/creatinine (UCr) ratio, one measurement of 24HUNa, and one measurement of sodium intake by dietary recall.
Results: The 24HUNa and mean spot UNa values were significantly lower in patients with more advanced CKD (P = 0.006 and P < 0.001, respectively). One-time spot UNa was significantly higher in the evening than in the morning for patients with stage III, IV, or V CKD. Total sodium intake, but not sodium nutrient density (milligrams of sodium per 1000 kcal), was significantly different for patients with different stages of CKD (P = 0.001). The correlation coefficient between 24HUNa and mean spot UNa was 0.477 (95% confidence interval [CI] 0.384-0.562, P < 0.001), slightly higher than that between 24HUNa excretion and mean spot UNa/UCr (r = 0.313, 95% CI 0.207-0.465, P < 0.001). There was a linear relation between spot UNa and 24HUNa: mean spot UNa = 0.27 × 24HUNa + 60. Therefore, a 24HUNa excretion of 87 mEq (sodium intake 2 g/d) corresponded to a mean spot UNa level of 83 mEq/L. The correlation coefficient between sodium intake and mean spot UNa was 0.435 (95% CI 0.336-0.524, P < 0.001), significantly higher than that between sodium intake and mean spot UNa/UCr (r = 0.197, 95% CI 0.091-0.301, P = 0.001). Mean spot UNa tended to be better correlated with 24HUNa than with sodium intake.
Conclusion: Mean spot UNa is a simple and effective method that can be used to monitor sodium intake in patients with CKD. A daily intake of 2 g of sodium corresponds to a mean spot UNa level of approximately 83 mEq/L in patients with CKD.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.nut.2011.06.006 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Association between urinary sodium-to-potassium ratio, elevated blood pressure phenotypes and microalbuminuria: Tehran Lipid and Glucose Study.
Sci Rep
November 2024
Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Article Synopsis
- This study analyzed the relationship between the urinary sodium to potassium ratio (UNa-K ratio), high blood pressure (BP) types, and microalbuminuria (MAU) in 1,782 adults from the Tehran Lipid and Glucose Study.
- It found that individuals with a higher UNa-K ratio (>3.14) had significantly greater chances of having isolated systolic hypertension (ISH), systolic-diastolic hypertension (SDH), and MAU compared to those with lower ratios.
- The results suggest that an increased UNa-K ratio is linked to a higher risk of hypertension and potential kidney issues.
Perioperative Metformin Treatment to Reduce Postoperative Hyperglycemia After Colon Cancer Surgery: A Randomized Clinical Trial.
Dis Colon Rectum
November 2024
Department of Surgery, Slagelse Hospital, Slagelse, Denmark.
Background: Surgery induces a stress response, causing insulin resistance that may result in postoperative hyperglycemia, which is associated with increased incidence of complications, longer hospitalization, and greater mortality.
Objective: This study examined the effect of metformin treatment on the percentage of patients experiencing postoperative hyperglycemia after elective colon cancer surgery.
Design: This was a randomized, double-blind, placebo-controlled trial.
Development and validation of a prediction model for estimating 24-Hour Urinary Sodium Excretion using spot urine samples in adult patients.
J Ren Nutr
September 2024
Clinical Biochemistry Department, Hospital Universitario Ramón y Cajal, IRYCIS. Madrid, Spain.
Unlabelled: The measurement of urinary sodium excretion provides valuable information about an individual's sodium balance and can help in the management of various medical conditions. However, the collection of 24-hour urine samples is subject to errors. Spot urine sodium (uNa) measurements are a reliable alternative to 24-hour urine collections for estimating urinary sodium excretion.
View Article and Find Full Text PDFRationale and Design of the DECONGEST (Diuretic Treatment in Acute Heart Failure With Volume Overload Guided by Serial Spot Urine Sodium Assessment) Study.
J Card Fail
August 2024
Centre for Cardiovascular Diseases, University Hospital Brussels, Jette, Belgium; Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium. Electronic address:
Aims: To evaluate whether early-combination diuretic therapy guided by serial post-diuretic urine sodium concentration (UNa) assessments in acute heart failure (AHF) facilitates safe and effective decongestion.
Methods: The Diuretic Treatment in Acute Heart Failure with Volume Overload Guided by Serial Spot Urine Sodium Assessment (DECONGEST) study is a pragmatic, 2-center, randomized, parallel-arm, open-label study aiming to enroll 104 patients with AHF and clinically evident fluid overload requiring treatment with intravenous loop diuretics. Patients are randomized to receive standard of care or a bundled approach comprising: (1) systematic post-diuretic UNa assessments until successful decongestion, defined as no remaining clinical signs of fluid overload with a post-diuretic UNa ≤ 80 mmol/L; (2) thrice-daily intravenous loop diuretic bolus therapy, with dosing according to estimated glomerular filtration rate; (3) upfront use of intravenous acetazolamide (500 mg once daily [OD]); and (4) full nephron blockade with high-dose oral chlorthalidone (100 mg OD) and intravenous canreonate (200 mg OD) for diuretic resistance, defined as persisting signs of fluid overload with a post-diuretic UNa ≤ 80 mmol/L.
Role of spot urinary sodium in outpatients with heart failure.
Rev Esp Cardiol (Engl Ed)
July 2024
Servicio de Cardiología, Hospital Clínico Universitario de Valencia, Valencia, Spain; Instituto de Investigación Sanitaria INCLIVA, Valencia, Spain; Facultad de Medicina, Universitat de València, Valencia, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Spain. Electronic address:
Introduction And Objectives: Spot determination of urinary sodium (UNa+) has emerged as a useful tool for monitoring diuretic response in patients with acute heart failure (AHF). However, the evidence in outpatients is scarce. We aimed to examine the relationship between spot UNa+ levels and the risk of mortality and worsening heart failure (WHF) events in individuals with chronic HF.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!